News | February 18, 2022
AptarGroup reported 2021 sales at US $3.23 billion
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
The commissioned facility has a capacity of 7,000 TPA to produce various Esters (Mono Methyl Acetoacetamide, Methyl Acetoacetate, Ethyl Acetoacetate, and Ter-Butyl Acetoacetate)
The device will facilitate the treatment of cerebral vasospasm following hemorrhagic stroke
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
The service has already been initiated in Maharashtra but being net-based it is easily available for patients all across the country
AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia
It will showcase the company’s latest technologies in robotics, digital health and orthopaedic implants
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
Adds five years of market exclusivity on approval
The vagus nerve is the longest nerve in the body that travels down from the brain to innervate and control breathing, stress levels and inflammation
Subscribe To Our Newsletter & Stay Updated
